The PSA and the Australasian Sleep Association have entered into a memorandum of understanding to support pharmacist education in sleep health and sleep science.
National President of PSA, Grant Kardachi, says this in turn will strengthen both organisations’ advocacy in order to achieve mutually agreed objectives to enhance patient outcomes.
The objectives of the MOU are to:
- develop and foster a strategic alliance that recognises, supports and promotes the professional role of pharmacists in the delivery of sleep health services as part of the primary health care team to improve patient outcomes;
- promote joint initiatives between the PSA and ASA, consistent with the vision of the two organisations;
- develop, promote and deliver a co-branded sleep training program focused initially on best practice CPAP Delivery for pharmacists across Australia; and
- promote collaborative research and exchange of information on specific mutually agreed issues.
“We are excited to announce that in collaboration and with input from relevant stakeholders, practice guidelines have been developed for the provision of sleep apnoea services within pharmacy and these will be launched at the PSA15 conference in July,” Kardachi says.
“In addition joint education modules are under development for release later this year and these will further enhance the role of pharmacists in this area.
“Moderate-to-severe sleep apnoea, if left untreated, can lead to health problems such as hypertension, cardiovascular disease, strokes, diabetes, and depression.
“Untreated sleep apnoea, in addition to being a health risk, is a safety risk for many people including long-distance drivers.
“Pharmacies are frequented by consumers due to easy access and convenience; and pharmacists and pharmacy staff who are educated and trained in this area are well placed to provide sleep apnoea services.”
ASA President Nick Antic says he is delighted with the partnership.
“We are very keen to help deliver best practice sleep care through pharmacies in Australia, and delighted the PSA shares the same vision. The partnership with the PSA will help us work together to achieve these aims,” he says.
“The two organisations are currently developing Guidelines for CPAP Delivery in Pharmacies and in time we hope to address broader sleep health issues including best practice insomnia management.
“The two organisations are running a short course in Melbourne in October just prior to the Australasian Sleep Association Annual Scientific meeting to help further develop skills in CPAP delivery in pharmacies.”